Optimapharm is a mid-size full-service pan-european CRO that has over 25 offices throughout Europe and is now a local Nordic CRO with the addition of Crown CRO joining the Optimapharm family in 2021.

Crown has operated in the Nordics since 2005 and this acquisition further strengthens access for Nordic pharma, biotech and medtech companies to utilize Optimapharms unrivaled access to patients in the Baltics and eastern Europe.

Faster start up times, high quality data and cost effective solutions has resulted in achieving 95% repeat business in supporting their clients for Phase I-IV, MDR, IVDR studies. Optimapharm provide a high level of expertise within oncology, cns, psychiatry, endocrinology, pulmonology, cardiovascular, rheumatology and vaccines to name a few.

Optimapharm provides a high level of expertise in developing and managing trials combined with a flexible tailor made and collaborative approach across Europe (and the US with their partners).

Here are a few of Optimapharm’s full, individual and out-source services that they offer across the Nordics and Europe:

  • Clinical project management
  • Regulatory Affairs
  • Monitoring
  • Feasibility
  • Biometrics, Data management and biostatistics
  • Quality Affairs, Safety and PV
  • Medical Affairs & medical writing
  • Short-term and Long-term insourcing